Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic

NCT04816656 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.

NCT NCT04816656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04816656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic
Lead sponsor
Jessa Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 3, 2020
Completion date
March 22, 2021
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic toxicity, covid19, oncology, proms